These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 12414619)
1. Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Wilson AJ; Velcich A; Arango D; Kurland AR; Shenoy SM; Pezo RC; Levsky JM; Singer RH; Augenlicht LH Cancer Res; 2002 Nov; 62(21):6006-10. PubMed ID: 12414619 [TBL] [Abstract][Full Text] [Related]
2. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Mariadason JM; Corner GA; Augenlicht LH Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808 [TBL] [Abstract][Full Text] [Related]
3. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729 [TBL] [Abstract][Full Text] [Related]
4. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE; Wang MX; Li RQ Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene. Gerner EW; Ignatenko NA; Lance P; Hurley LH Ann N Y Acad Sci; 2005 Nov; 1059():97-105. PubMed ID: 16382048 [TBL] [Abstract][Full Text] [Related]
6. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival. Alves-Guerra MC; Ronchini C; Capobianco AJ Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709 [TBL] [Abstract][Full Text] [Related]
7. The chemopreventive agent sulindac attenuates expression of the antiapoptotic protein survivin in colorectal carcinoma cells. Zhang T; Fields JZ; Ehrlich SM; Boman BM J Pharmacol Exp Ther; 2004 Feb; 308(2):434-7. PubMed ID: 14610217 [TBL] [Abstract][Full Text] [Related]
8. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas. Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383 [TBL] [Abstract][Full Text] [Related]
10. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling. Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625 [TBL] [Abstract][Full Text] [Related]
11. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320 [TBL] [Abstract][Full Text] [Related]
12. Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines. Dillard AC; Lane MA Mol Carcinog; 2007 Apr; 46(4):315-29. PubMed ID: 17219422 [TBL] [Abstract][Full Text] [Related]
13. Sulindac sulfone is most effective in modulating beta-catenin-mediated transcription in cells with mutant APC. Chang WC; Everley LC; Pfeiffer GR; Cooper HS; Barusevicius A; Clapper ML Ann N Y Acad Sci; 2005 Nov; 1059():41-55. PubMed ID: 16382042 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression. Yekkala K; Baudino TA Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987 [TBL] [Abstract][Full Text] [Related]
15. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Pálmer HG; Sánchez-Carbayo M; Ordóñez-Morán P; Larriba MJ; Cordón-Cardó C; Muñoz A Cancer Res; 2003 Nov; 63(22):7799-806. PubMed ID: 14633706 [TBL] [Abstract][Full Text] [Related]
16. Growth factor-dependent regulation of survivin by c-myc in human breast cancer. Cosgrave N; Hill AD; Young LS J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079 [TBL] [Abstract][Full Text] [Related]
17. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Takahashi M; Nakamura Y; Obama K; Furukawa Y Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906 [TBL] [Abstract][Full Text] [Related]
19. Keratinocyte transcriptional regulation of the human c-Myc promoter occurs via a novel Lef/Tcf binding element distinct from neoplastic cells. Kolly C; Zakher A; Strauss C; Suter MM; Müller EJ FEBS Lett; 2007 May; 581(10):1969-76. PubMed ID: 17466981 [TBL] [Abstract][Full Text] [Related]
20. Truncated APC regulates the transcriptional activity of beta-catenin in a cell cycle dependent manner. Schneikert J; Grohmann A; Behrens J Hum Mol Genet; 2007 Jan; 16(2):199-209. PubMed ID: 17189293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]